Organs-on-chips Market

Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022

Report Code: BT 5883 Jan, 2018, by marketsandmarkets.com

[117 Pages Report] The organs-on-chips market is expected to reach USD 45.6 Million by 2022 from USD 7.8 Million in 2016, at a CAGR of 36.6%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

The objectives of this study are as follows:

  • To define, describe, segment, and forecast the global organs-on-chips market by product, type, application, and end user
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders
  • To forecast the size of the market with respect to four regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, agreements, and collaborations, product launch, and , expansions in the organs-on-chips market

Research Methodology

The study estimates the organs-on-chips market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the organs-on-chips market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the organs-on-chips market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Secondary sources such as National Institute of Environmental Health Sciences, American Society for Biochemistry and Molecular Biology, Society for In Vitro Biology, European Society for Animal Cell Technology, and UK Society for Cell Culture Biotechnology were referred.

Organs-on-chips Market

To know about the assumptions considered for the study, download the pdf brochure

The organs-on-ships market is highly competitive with the presence various players. Some of the players operating in the market are CN Bio (UK), Emulate (US), TissUse (Germany), Mimetas (Netherlands), InSphero (Switzerland), Ascendance Bio (US), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

Target Audience for this Report:

  • Pharmaceutical and biotechnology companies
  • Chemical companies
  • Healthcare providers and diagnostic laboratories
  • Manufacturers of 3D cell culture products
  • Food & beverage manufacturers
  • Contract research organizations (CROs)
  • Research institutes/universities
  • Research and consulting firms
  • Venture capitalists

Scope of the Report

This report categorizes the organs-on-chips market into following segments and subsegments:

By Type

  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Other Organs

By Offerings

  • Products
  • Services

By Application

  • Physiological Model Development
  • Drug Discovery
  • Toxicology Research

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cosmetics Industry
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • RoE
  • Asia
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

The organs-on-chips market is expected to reach USD 45.6 Million by 2022 from USD 9.6 Million in 2017, at a CAGR of 36.6%. The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and new products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure.

This report segments the organs-on-chips market into type, offerings, application, end user, and region. Based on type, the organs-on-chips market is segmented into liver, lung, heart, kidney, and other organs-on-chips. In 2017, the accessories segment is expected to account for the largest share of the organs-on-chips market. The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.

Based on application, the organs-on-chips market is segmented into physiological model development, drug discovery, and toxicology research. The drug discovery segment is expected to register the highest CAGR during the forecast period.

Organs-on-chips Market

In 2017, North America is expected to account for the largest share and also expected to grow at the highest CAGR of the market followed by Europe. The largest share and high growth of this market is attributed to the factors such as the availability of new and advanced organs-on-chips models in the market, favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies.

Issues related to the incorporation of organs-on-chips technologies into existing workflows, and complexity of organs-on-chips models may limit market growth to a certain extent in the coming years. The organs-on-chips market is emerging and competitive in nature, with a number of small players competing for market space (including startups firms). Prominent players in this market include Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), Ascendance Bio (US), CN Bio (UK), TissUse (Germany), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 11)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 14)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 22)

4 Premium Insights (Page No. - 26)
    4.1 Organs-on-Chips Market Overview
    4.2 Europe: Organs-on-Chips Market, By Application & Country
    4.3 Organs-on-Chips Market, By Type
    4.4 Organs-on-Chips Market, By Application

5 Market Overview (Page No. - 29)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Focus on Developing Alternatives for Animal Testing Models
                    5.2.1.2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Organs-on-Chips
                    5.2.1.3 Technological Advancements and New Products Launches
                    5.2.1.4 Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Organs-on-Chips Manufacturers
                    5.2.1.5 Growing Need for Early Detection of Drug Toxicity to Minimize Financial Losses Due to Late Stage Drug Failure
                    5.2.1.6 Growing Initiatives to Increase Awareness About Organs-on-Chips Technologies
           5.2.2 Restraint
                    5.2.2.1 Issues Related to the Incorporation of Organs-on-Chips Technologies Into Existing Workflows
           5.2.3 Opportunities
                    5.2.3.1 Increasing Focus on Drug Discovery Activities
                    5.2.3.2 Application of Organs-on-Chips in Oncology Research
                    5.2.3.3 Development of Multiple-Organs-on-A-Chip Models
           5.2.4 Challenges
                    5.2.4.1 Complexity of Organs-on-Chips Models
                    5.2.4.2 Dearth of Skilled Professionals
    5.3 Funding and Venture Capital Investments

6 Organs-on-Chips Market, By Type (Page No. - 38)
    6.1 Introduction
    6.2 Liver
    6.3 Heart
    6.4 Lung
    6.5 Kidney
    6.6 Other Organs

7 Organs-on-Chips Market, By Offering (Page No. - 46)
    7.1 Introduction
    7.2 Products
    7.3 Services

8 Organs-on-Chips Market, By Application (Page No. - 50)
    8.1 Introduction
    8.2 Physiological Model Development
    8.3 Drug Discovery
    8.4 Toxicology Research

9 Organs-on-Chips Market, By End User (Page No. - 58)
    9.1 Introduction
    9.2 Pharmaceutical & Biotechnology Companies
    9.3 Academic & Research Institutes
    9.4 Cosmetics Industry
    9.5 Other End Users

10 Organs-on-Chips Market, By Region (Page No. - 67)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 UK
             10.3.3 RoE
     10.4 Asia
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 88)
     11.1 Overview
     11.2 Ranking of Players, 2016
     11.3 Competitive Situation and Trends
             11.3.1 Agreements, Partnerships, and Collaborations
             11.3.2 Product Launches
             11.3.3 Expansions

12 Company Profiles (Page No. - 92)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
     12.1 Emulate
     12.2 CN Bio
     12.3 Tissuse
     12.4 Mimetas
     12.5 Insphero
     12.6 Ascendance Bio
     12.7 Kirkstall
     12.8 Hurel
     12.9 Synvivo
     12.10 Axosim
     12.11 Nortis

*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 109)
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (68 Tables)

Table 1 Key Product Launches/Upgrades
Table 2 Funding & Venture Capital Investments
Table 3 Organs-on-Chips Market, By Type, 2015–2022 (USD Million)
Table 4 Liver-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 5 North America: Liver-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 6 Heart-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 7 North America: Heart-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 8 Lung-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 9 North America: Lung-on-A-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 10 Kidney-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 11 North America: Kidney-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 12 Other Organs-on-Chips Market, By Region, 2015–2022 (USD Thousand)
Table 13 North America: Other Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 14 Organs-on-Chips Market, By Offering, 2015–2022 (USD Million)
Table 15 North America: Organs-on-Chips Products Market, By Country, 2015–2022 (USD Thousand)
Table 16 North America: Organs-on-Chips Services Market, By Country, 2015–2022 (USD Thousand)
Table 17 Organs-on-Chips Market, By Application, 2015–2022 (USD Million)
Table 18 Organs-on-Chips Market for Physiological Model Development, By Region, 2015–2022 (USD Thousand)
Table 19 North America: Organs-on-Chips Market for Physiological Model Development, By Country, 2015–2022 (USD Thousand)
Table 20 Europe: Organs-on-Chips Market for Physiological Model Development, By Country, 2015–2022 (USD Thousand)
Table 21 Organs-on-Chips Market for Drug Discovery, By Region, 2015–2022 (USD Thousand)
Table 22 North America: Organs-on-Chips Market for Drug Discovery, By Country, 2015–2022 (USD Thousand)
Table 23 Europe: Organs-on-Chips Market for Drug Discovery, By Country, 2015–2022 (USD Thousand)
Table 24 Organs-on-Chips Market for Toxicology Research, By Region, 2015–2022 (USD Thousand)
Table 25 North America: Organs-on-Chips Market for Toxicology Research, By Country, 2015–2022 (USD Thousand)
Table 26 Europe: Organs-on-Chips Market for Toxicology Research, By Country, 2015–2022 (USD Thousand)
Table 27 Organs-on-Chips Market, By End User, 2015–2022 (USD Million)
Table 28 Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Thousand)
Table 29 North America: Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Thousand)
Table 30 Europe: Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Thousand)
Table 31 Organs-on-Chips Market for Academic & Research Institutes, By Region, 2015–2022 (USD Thousand)
Table 32 North America: Organs-on-Chips Market for Academic & Research Institutes, By Country, 2015–2022 (USD Thousand)
Table 33 Europe: Organs-on-Chips Market for Academic & Research Institutes, By Country, 2015–2022 (USD Thousand)
Table 34 Organs-on-Chips Market for Cosmetics Industry, By Region, 2015–2022 (USD Thousand)
Table 35 North America: Organs-on-Chips Market for Cosmetics Industry, By Country, 2015–2022 (USD Thousand)
Table 36 Europe: Organs-on-Chips Market for Cosmetics Industry, By Country, 2015–2022 (USD Thousand)
Table 37 Organs-on-Chips Market for Other End Users, By Region, 2015–2022 (USD Thousand)
Table 38 North America: Organs-on-Chips Market for Other End Users, By Country, 2015–2022 (USD Thousand)
Table 39 Europe: Organs-on-Chips Market for Other End Users, By Country, 2015–2022 (USD Thousand)
Table 40 Organs-on-Chips Market, By Region, 2015–2022 (USD Million)
Table 41 North America: Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 42 North America: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 43 North America: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 44 North America: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 45 North America: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 46 US: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 47 US: Organs-on-Chips Market, By Application, 2015–2022 (USD Million)
Table 48 US: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 49 Canada: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 50 Canada: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 51 Canada: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 52 Europe: Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 53 Europe: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 54 Europe: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 55 Europe: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 56 Europe: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 57 Germany: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 58 Germany: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 59 UK: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 60 UK: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 61 RoE: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 62 RoE: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 63 Asia: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 64 Asia: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 65 Asia: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 66 RoW: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 67 RoW: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 68 Organs-on-Chips Market Ranking Analysis, By Key Player (2016)


List of Figures (27 Figures)

Figure 1 Research Design
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Break Down of Primary Interviews: By Company, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Liver-on-A-Chip Market to Grow at the Highest Rate During the Forecast Period
Figure 7 Services Segment to Witness Highest Growth During the Forecast Period
Figure 8 Drug Discovery Segment to Register the Highest Rate During the Forecast Period
Figure 9 Pharmaceutical & Biotechnology Companies to Dominate the Organs-on-Chips End-User Market During the Forecast Period
Figure 10 North America to Witness Highest Growth During the Forecast Period (2017–2022)
Figure 11 Focus on Developing Alternatives to Animal Testing to Drive the Growth of the Market
Figure 12 Toxicology Research to Hold the Largest Share of the Organs-on-Chips Market in Europe(2017)
Figure 13 Liver Segment to Witness High Growth From 2017 to 2022
Figure 14 Toxicology Research Segment to Dominate the Organs-on-Chips Market in 2017
Figure 15 Organs-on-Chips Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Number of Registered Clinical Trial Studies (2005–2017)
Figure 17 Liver Segment to Dominate the Organs-on-Chips Market During the Forecast Period
Figure 18 Services Segment to Dominate the Organs-on-Chips Market During the Forecast Period
Figure 19 Toxicology Research is Estimated to Be the Largest Application Segment in the Organs-on-Chips Market
Figure 20 Pharmaceutical & Biotechnology Companies Will Continue to Dominate the Organs-on-Chips Market in 2022
Figure 21 North America Will Continue to Dominate the Organs-on-Chips Market in 2022
Figure 22 North America: Organs-on-Chips Market Snapshot
Figure 23 Europe: Organs-on-Chips Market Snapshot
Figure 24 Asia: Organs-on-Chips Market Snapshot
Figure 25 RoW: Organs-on-Chips Market Snapshot
Figure 26 Strategies Adopted By Market Players (2014–2017)
Figure 27 Market Evolution Framework


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 5883
Published ON
Jan, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Organs-on-chips Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved